Health Highlights: Nov. 7, 2022

Amid a surge of RSV, hope for new vaccines. As many as four new RSV vaccine candidates could soon be sent for review by the U.S. Food and Drug Administration, experts say, and dozens more are in testing or under development. Read more
Is surgery always necessary for chronic chest pain? A new clinical trial finds patients' overall risk of death is about the same whether they choose aggressive surgical treatment or a more conservative approach focused on medication and lifestyle changes. Read more
Paxlovid might cut odds for long COVID. A new analysis showed people treated with the drug had a 26% reduced risk of developing several long COVID conditions, including heart disease, blood disorders, fatigue and other issues. Read more
Related Posts
School-Based Intervention Cuts Psychotic Experiences in Teens
TUESDAY, Feb. 28, 2023 (HealthDay News) -- A school-based screening and referral...
New Competitor to Wegovy Shows Promise in Clinical Trials
TUESDAY, June 27, 2023 (HealthDay News) -- An experimental drug appears to...
Tying the Knot Could Keep High Blood Sugar at Bay
WEDNESDAY, Feb. 8, 2023 (HealthDay News) -- Getting hitched could help...
Devastating Tornadoes Leave Hazards in Their Wake: Tips to Stay Safe
TUESDAY, April 4, 2023 (HealthDay News) -- Tornadoes bring with them many...
